Unlearn Receives Funding for Clinical Trial Digital Twin Tech

Unlearn Secures $50m in Series C Funding for Clinical Research with Digital Twin Technology

AI company Unlearn has raised $50m in a Series C funding round led by Altimeter Capital. The funding will support Unlearn’s mission to use artificial intelligence (AI) to optimize clinical research through digital twin technology. Return investors Wittington Ventures, Radical Ventures, Mubadala Capital, Epic Ventures, and Necessary Venture Capital also participated in the funding round, along with new investors Insight Partners, 8VC, DCVC, and DCVC Bio.